CUREVAC NV (CVAC) Stock Analyst Ratings
USA - NASDAQ:CVAC - NL0015436031 - Common Stock
5.35 USD
-0.01 (-0.19%)
ChartMill assigns a Buy % Consensus number of 72% to CVAC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.92. This target is -8.1% below the current price.
CVAC was analyzed by 13 analysts. The buy percentage consensus is at 72. So analysts seem to be have mildly positive about CVAC.
In the previous month the buy percentage consensus was at a similar level.
CVAC was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-06-26 | UBS | Downgrade | Buy -> Neutral |
| 2025-06-13 | Jefferies | Downgrade | Buy -> Hold |
| 2025-05-28 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-04-30 | UBS | Maintains | Buy -> Buy |
| 2025-02-14 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-09-16 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-08-16 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-07-03 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-04-25 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-04-05 | Guggenheim | Reiterate | Neutral |
| 2023-08-21 | B of A Securities | Maintains | Underperform -> Underperform |
| 2023-06-08 | SVB Securities | Initiate | Outperform |
| 2023-04-26 | JMP Securities | Maintains | Outperform |
| 2023-01-19 | UBS | Upgrade | Neutral -> Buy |
| 2023-01-09 | Jefferies | Upgrade | Hold -> Buy |
| 2022-11-17 | JMP Securities | Maintains | Market Outperform |
| 2022-04-22 | JMP Securities | Maintains | Market Outperform |
| 2022-01-21 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2022-01-18 | JMP Securities | Initiate | Market Outperform |
| 2021-10-22 | Deutsche Bank | Initiate | Hold |
| 2021-06-17 | B of A Securities | Downgrade | Buy -> Neutral |
| 2021-04-26 | Guggenheim | Initiate | Buy |
CUREVAC NV / CVAC FAQ
What do analysts expect the price target to be for CUREVAC NV (CVAC)?
13 analysts have analysed CVAC and the average price target is 4.92 USD. This implies a price decrease of -8.1% is expected in the next year compared to the current price of 5.35.
What is the consensus rating for CVAC stock?
The consensus rating for CUREVAC NV (CVAC) is 72.3077 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover CUREVAC NV (CVAC) stock?
The number of analysts covering CUREVAC NV (CVAC) is 13.